GN25 ≥98%
Synonyms:
3-[(1,4-dihydro-5,8-dimethoxy-1,4-dioxo-2-naphthalenyl)thio]-propanoic acid
, p53-Snail binding Inhibitor
GN25 blocks Snail binding to p53 and induces p53 expression in cancer cells in a KRas dependent manner.
- Yields antitumoral effects
- Notably reduce tumor size and progression
- Significantly reduces cell proliferation in KRas mutated A549 and HCT116 cell lines
Oncogenic KRas has been shown to inhibit p53 function by inducing Snail to bind and eliminate p53 through exocytosis. At 10 μM, GN25 significantly reduces cell proliferation in KRas mutated A549 and HCT116 cell lines but not in wild type MKN-45 cells. In a xenograft mouse model, 10 mg/kg GN25 yields antitumoral effects by notably reducing tumor size and progression.
Formula:
C₁₅H₁₄O₆S MW: 322.3 g/mol |
CAS Number:
1227401-27-5 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...